Cannabis Impairs Driving in Simulator Study, Even When Users Feel Fine

A randomized driving simulator trial showed cannabis impaired key driving metrics even when participants did not feel significantly impaired.

Meda, Shashwath A et al.·Journal of psychopharmacology (Oxford·2025·Moderate EvidenceRandomized Controlled Trial
RTHC-07109Randomized Controlled TrialModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Randomized Controlled Trial
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

In a controlled simulator study, cannabis administration led to measurable driving impairment including lane weaving and reaction time delays, even when participants self-reported feeling capable of driving.

Key Numbers

Randomized trial with driving simulator; specific impairment metrics and THC doses in full text.

How They Did This

Randomized, controlled driving simulator study where participants received cannabis or placebo and completed standardized driving tasks while objective and subjective impairment were measured.

Why This Research Matters

The disconnect between feeling capable and actually being impaired is a critical safety issue, especially as cannabis legalization expands and more people drive after using.

The Bigger Picture

Unlike alcohol, cannabis impairment is harder to self-detect. This gap between perceived and actual impairment complicates road safety efforts and public messaging about drugged driving.

What This Study Doesn't Tell Us

Simulator driving may not perfectly replicate real-world conditions. Acute dosing in a lab does not capture the full range of cannabis use patterns. Tolerance effects in regular users may differ.

Questions This Raises

  • ?How long after cannabis use does driving impairment persist?
  • ?Can any self-assessment tool reliably help users gauge their fitness to drive?

Trust & Context

Key Stat:
Driving impairment detected even when participants felt capable of driving
Evidence Grade:
Randomized controlled design provides strong internal validity, though simulator setting limits real-world generalizability.
Study Age:
2025 randomized controlled trial with current road safety relevance.
Original Title:
A randomized, placebo-controlled, double-blind, pilot study of cannabis-related driving impairment assessed by driving simulator and self-report.
Published In:
Journal of psychopharmacology (Oxford, England), 39(4), 364-372 (2025)
Database ID:
RTHC-07109

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled TrialGold standard for testing treatments
This study
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal Study

Participants are randomly assigned to treatment or placebo groups to test cause and effect.

What do these levels mean? →

Frequently Asked Questions

Can you tell if you are too impaired to drive after cannabis?

This study suggests not reliably. Participants showed measurable driving impairment on the simulator even when they reported feeling capable of driving safely.

How does cannabis affect driving ability?

The simulator study found cannabis caused lane weaving and slower reaction times, both key factors in real-world crash risk.

Read More on RethinkTHC

Cite This Study

RTHC-07109·https://rethinkthc.com/research/RTHC-07109

APA

Meda, Shashwath A; Stevens, Michael C; Boer, Erwin R; Pittman, Brian; Gueorguieva, Ralitza; Huestis, Marilyn A; Pearlson, Godfrey D. (2025). A randomized, placebo-controlled, double-blind, pilot study of cannabis-related driving impairment assessed by driving simulator and self-report.. Journal of psychopharmacology (Oxford, England), 39(4), 364-372. https://doi.org/10.1177/02698811251324379

MLA

Meda, Shashwath A, et al. "A randomized, placebo-controlled, double-blind, pilot study of cannabis-related driving impairment assessed by driving simulator and self-report.." Journal of psychopharmacology (Oxford, 2025. https://doi.org/10.1177/02698811251324379

RethinkTHC

RethinkTHC Research Database. "A randomized, placebo-controlled, double-blind, pilot study ..." RTHC-07109. Retrieved from https://rethinkthc.com/research/meda-2025-a-randomized-placebocontrolled-doubleblind

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.